Mavengity Expands into B2B Research
Owner Marko Pargo Ivanov is now writing the B2B Research desk directly, turning Forrester and Gartner category reports into plain-English breakdowns for buyers.
Read the ArticleUPMC and NYU Langone agreed to end pediatric gender-affirming care without admitting wrongdoing. The DOJ's tool is the False Claims Act, and the pattern is turning settlements into national policy.
The SEC proposes to rescind Rule 14a-8 on grounds it never had the authority. If it succeeds, the right to bring a proposal will depend on where a company is incorporated.
A KFF Health News analysis found nearly 600 required postmarket studies behind schedule, covering almost 350 products still on the market. The system's incentives reward the company that never finishes.
Ireland's data regulator fined Google over location-data practices that ended in 2020. The penalty is less about current harm than about whether the company could prove what it did, and the enforcement clock is the story.
The Jane Street loss inquiry is really about intraday risk: how fast a bank's exposure to a trading firm can move between two reporting windows, and whether end-of-day capital rules can see it.
The $2.35 billion ITM merger is nominally about a neuroendocrine tumor drug. The binding asset is commercial-scale lutetium-177 production, and the deal reorders who controls the isotope supply chain.
The draft order would route the $48 billion research budget through unanimous political approval, and the NIH director who just refused to cut Harvard's funding would hold one of the seats.
The Bessent-He meeting left the trade truce on its November 10 clock. The genuinely new piece is a channel for telling each other when an AI system goes wrong.
All 50 states, D.C., and Puerto Rico are joining the most-favored-nation model, while the deals that set the prices have never been published.
Non-English intent signal is still under twenty percent of total volume industrywide, which means most platforms are seeing a fraction of the buying activity happening outside English language markets.
One vendor is explicitly competing on restraint, arguing that a plausible AI generated article that is subtly wrong is worse for a knowledge base than no article at all.
Forrester's own buyer guidance undercuts the AI pitch: providers are getting measurably more efficient, and there is little evidence yet that any of that efficiency is reaching customer pricing.
Forrester's guidance to buyers is blunt: having a data centre in the EU answers one sovereignty question out of four, and most vendor pitches stop at the first.
Forrester frames 2026's binding constraint as a workforce that cannot be trained fast enough, which makes this a services category built around people more than platforms.
Generative AI should have commoditized this category, and instead Forrester's criteria count kept climbing, because the moat was always licensed source access, not summarization.
Two of the category's most prominent independent players are now owned by the card networks they were supposed to route around.
Forrester's provider count nearly doubled in three years, and every other technology category in this series points at the same root cause: the software works and the organisation does not change.
Every reference customer for one vendor said they would buy again, which in PLM can mean genuine excellence or a customer base that has nowhere else to go once the evidence chain is built.
Owner Marko Pargo Ivanov is now writing the B2B Research desk directly, turning Forrester and Gartner category reports into plain-English breakdowns for buyers.
Read the ArticleWith James now writing full time for our Healthcare & Medical desk, Mavengity has formally expanded into dedicated medical authorship.
Read the Article